The Disease Awareness section has been reviewed for clinical accuracy by Prof. Dr. Stephan Stilgenbauer, MD (last updated January 2018).
Recently added: Our new EACCME accredited CME entitled: 'Personalisation of chronic lymphocytic leukaemia (CLL) care'. Earn your credits now!
Discussing Chronic Lymphocytic Leukaemia (CLL) including clonal proliferation and accumulation of CD5+CD23+ B-cells, signalling mechanisms, genetic aberrations in 13q14, 11q22-q23 and 17p13, trisomy 12, diagnosis and treatment options.
Ibritunib therapy has high efficacy and a favourable toxicity profile in the treatment of chronic lymphocytic leukaemia (CLL). However, recent data suggest that it is not always administered optimally in clinical practice.
View key resources from recent oncologic and haematologic congresses, providing an insight into the latest advances in CLL care.
Explore upcoming events within the fields of haematology and oncology.
View useful links to national societies and various healthcare organisations to enhance your knowledge of CLL.
Personalisation of chronic lymphocytic leukaemia (CLL) care is an EACCME accredited CME that will help you understand your patient’s CLL.
Alternatively login via
Back to epgonline.org